IM
| Title | Published in | Access level | OA Policy | Year | Views | Downloads | |
|---|---|---|---|---|---|---|---|
| HMGB1 promotes CXCL12‐dependent egress of murine B cells from Peyer's patches in homeostasis | European Journal of Immunology |  | 2021 | 256 | 163 | ||
| Polymer-coated gold nanospheres do not impair the innate immune function of human B lymphocytes in vitro | ACS Nano | | 2019 | 450 | 537 | ||
| Development of resiquimod-loaded modified PLA-based nanoparticles for cancer immunotherapy: A kinetic study | European Journal of Pharmaceutics and Biopharmaceutics | | 2019 | 584 | 681 | ||
| Amphiphilic nanoparticle delivery enhances the anticancer efficacy of a TLR7 ligand via local immune activation | Biomaterials | | 2019 | 538 | 648 | ||
| Nanoparticles for lymph node delivery of antigenic peptides or immunostimulants to improve cancer immunotherapy | | 2018 | 731 | 573 | |||
| Polymer-based nanoparticles loaded with a TLR7 ligand to target the lymph node for immunostimulation | International Journal of Pharmaceutics | | 2018 | 643 | 826 | ||
| Engineered hybrid spider silk particles as delivery system for peptide vaccines | Biomaterials | | 2018 | 572 | 449 | ||
| Antimicrobial silver-filled silica nanorattles with low immunotoxicity in dendritic cells | Nanomedicine | | 2017 | 545 | 547 | ||
| A rapid screening method to evaluate the impact of nanoparticles on macrophages | Nanoscale | | 2017 | 505 | 392 | ||
| Reprogramming of TLR7 signaling enhances antitumor NK and cytotoxic T cell responses | Oncoimmunology | | 2016 | 244 | 150 | ||
| TLR7-based cancer immunotherapy decreases intratumoral myeloid-derived suppressor cells and blocks their immunosuppressive function | Oncoimmunology | | 2016 | 235 | 183 |
